Ash Bullement

17PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsHaematological tumoursPredictive and prognostic markersTime-series analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 19, 2025
Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy.

Philipp Ivanyi, Ash Bullement, Andrea Botticelli

|Aug 29, 2024
MPES-R: Multi-Parameter Evidence Synthesis in R for Survival Extrapolation-A Tutorial.

Ash Bullement, Mark Edmondson-Jones, Patricia Guyot

|Apr 27, 2024
Advances in Addressing Patient Heterogeneity in Economic Evaluation: A Review of the Methods Literature.

Gemma E Shields, Paul Clarkson, Ash Bullement

|Apr 25, 2024
"Don't keep me waiting": estimating the impact of reduced vein-to-vein time on lifetime US 3L+ LBCL patient outcomes.

Sachin Vadgama, Marcelo C Pasquini, Richard T Maziarz

|Aug 02, 2023
Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland.

Simone Critchlow, Ash Bullement, Simon Crabb

|May 01, 2023
A Systematic Review of Methods to Incorporate External Evidence into Trial-Based Survival Extrapolations for Health Technology Assessment.

Ash Bullement, Matthew D Stevenson, Gianluca Baio

Pageof 3

Frequent Collaborators

7 joint publications

Gemma E Shields

3 joint publications

Emma S Knowles

3 joint publications

Anthony James Hatswell

3 joint publications

Holly L Cranmer